{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:16:20Z","timestamp":1790072180792,"version":"4.0.1"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH R21","award":["1R21CA188818-01A1"],"award-info":[{"award-number":["1R21CA188818-01A1"]}]},{"name":"SKY Foundation"},{"name":"James H. Thie Foundation"},{"DOI":"10.13039\/100008982","name":"QNRF","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008982","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Perri Foundation"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.semcancer.2016.01.002","type":"journal-article","created":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T16:55:09Z","timestamp":1453395309000},"page":"95-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["F-BOX proteins in cancer cachexia and muscle wasting: Emerging regulators and therapeutic opportunities"],"prefix":"10.1016","volume":"36","author":[{"given":"Ammar","family":"Sukari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irfana","family":"Muqbil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramzi M.","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip A.","family":"Philip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asfar S.","family":"Azmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2016.01.002_bib0005","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/ajcn\/83.6.1345","article-title":"Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis","volume":"83","author":"Fearon","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0010","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2354.2006.00760.x","article-title":"Cancer chemotherapy and cachexia: mirtazapine and olanzapine are 5-HT3 antagonists with good antinausea effects","volume":"16","author":"Kast","year":"2007","journal-title":"Eur. J. Cancer Care (Engl.)"},{"key":"10.1016\/j.semcancer.2016.01.002_bib0015","first-page":"98","article-title":"Supportive nutrition to prevent cachexia and improve quality of life","volume":"22","author":"Ottery","year":"1995","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0020","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/SPC.0b013e32830f47e4","article-title":"Cyclooxygenase-2 inhibitors and antioxidants in the treatment of cachexia","volume":"2","author":"Mantovani","year":"2008","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"10.1016\/j.semcancer.2016.01.002_bib0025","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s13539-014-0142-1","article-title":"Psychosocial impact of cancer cachexia","volume":"5","author":"Hopkinson","year":"2014","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.semcancer.2016.01.002_bib0030","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/SPC.0b013e32833ef813","article-title":"The emotional aspects of cancer anorexia","volume":"4","author":"Hopkinson","year":"2010","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"10.1016\/j.semcancer.2016.01.002_bib0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.pan.2014.11.006","article-title":"Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: a systematic review","volume":"15","author":"Ozola Zalite","year":"2015","journal-title":"Pancreatology"},{"key":"10.1016\/j.semcancer.2016.01.002_bib0040","doi-asserted-by":"crossref","first-page":"e83618","DOI":"10.1371\/journal.pone.0083618","article-title":"Clinical classification of cancer cachexia: phenotypic correlates in human skeletal muscle","volume":"9","author":"Johns","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2016.01.002_bib0045","first-page":"9361","article-title":"Cachexia and pancreatic cancer: are there treatment options","volume":"20","author":"Mueller","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0050","first-page":"363","article-title":"Liver macrophages contribute to pancreatic cancer-related cachexia","volume":"21","author":"Martignoni","year":"2009","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0055","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1042\/cs0960083","article-title":"Relationship of serum levels of interleukin-6, soluble interleukin-6 receptor and tumour necrosis factor receptors to the acute-phase protein response in advanced pancreatic cancer","volume":"96","author":"Barber","year":"1999","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.semcancer.2016.01.002_bib0060","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1477-2574.2010.00178.x","article-title":"Cachexia in pancreatic cancer: new treatment options and measures of success","volume":"12","author":"Fearon","year":"2010","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.semcancer.2016.01.002_bib0065","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/B978-0-12-405210-9.00002-3","article-title":"Insights into skeletal muscle development and applications in regenerative medicine","volume":"300","author":"Tran","year":"2013","journal-title":"Int. Rev. Cell Mol. Biol."},{"issue":"Suppl. 1","key":"10.1016\/j.semcancer.2016.01.002_bib0070","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s40520-015-0427-z","article-title":"Sarcopenia: a histological and immunohistochemical study on age-related muscle impairment","volume":"27","author":"Tarantino","year":"2015","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0075","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5535\/arm.2015.39.2.155","article-title":"Aging of skeletal muscle fibers","volume":"39","author":"Miljkovic","year":"2015","journal-title":"Ann. Rehabil. Med."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0080","article-title":"Sarcopenia and inflammation are independent predictors of survival in male patients newly diagnosed with small cell lung cancer","author":"Go","year":"2015","journal-title":"Support Care Cancer"},{"issue":"12","key":"10.1016\/j.semcancer.2016.01.002_bib0085","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1097\/JTO.0000000000000690","article-title":"Prognostic significance of CT-determined sarcopenia in patients with small-cell lung cancer","volume":"10","author":"Kim","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0090","doi-asserted-by":"crossref","DOI":"10.1016\/S0261-5614(15)30121-7","article-title":"The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma","author":"Rollins","year":"2015","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0095","article-title":"Sarcopenia evaluated using the skeletal muscle index is a significant prognostic factor for metastatic urothelial carcinoma","author":"Taguchi","year":"2015","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.semcancer.2016.01.002_bib0100","article-title":"Prognostic and clinical impact of sarcopenia in esophageal squamous cell carcinoma","author":"Harada","year":"2015","journal-title":"Dis. Esophagus"},{"key":"10.1016\/j.semcancer.2016.01.002_bib0105","doi-asserted-by":"crossref","first-page":"39597","DOI":"10.1074\/jbc.M110.129718","article-title":"Muscle wasting in aged, sarcopenic rats is associated with enhanced activity of the ubiquitin proteasome pathway","volume":"285","author":"Altun","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0110","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrc3700","article-title":"Roles of F-box proteins in cancer","volume":"14","author":"Wang","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2016.01.002_bib0115","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrm2673","article-title":"Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways","volume":"10","author":"Schulman","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0120","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrm2780","article-title":"Building ubiquitin chains: E2 enzymes at work","volume":"10","author":"Ye","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0125","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/416703a","article-title":"Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex","volume":"416","author":"Zheng","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2016.01.002_bib0130","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1098\/rstb.1999.0497","article-title":"SCF ubiquitin protein ligases and phosphorylation-dependent proteolysis","volume":"354","author":"Willems","year":"1999","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0135","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1128\/MCB.20.4.1382-1393.2000","article-title":"The SCF(HOS\/beta-TRCP)-ROC1 E3 ubiquitin ligase utilizes two distinct domains within CUL1 for substrate targeting and ubiquitin ligation","volume":"20","author":"Wu","year":"2000","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0140","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.cellbio.15.1.435","article-title":"SCF and Cullin\/Ring H2-based ubiquitin ligases","volume":"15","author":"Deshaies","year":"1999","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0145","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nature13644","article-title":"Structural biology: corralling a protein-degradation regulator","volume":"512","author":"Deshaies","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2016.01.002_bib0150","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.cell.2013.02.024","article-title":"Cand1 promotes assembly of new SCF complexes through dynamic exchange of F box proteins","volume":"153","author":"Pierce","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2016.01.002_bib0155","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1038\/ncomms2636","article-title":"CAND1 controls in vivo dynamics of the cullin 1-RING ubiquitin ligase repertoire","volume":"4","author":"Wu","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0160","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/ncomms2628","article-title":"CSN- and CAND1-dependent remodelling of the budding yeast SCF complex","volume":"4","author":"Zemla","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0165","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1053\/ajkd.2001.20764","article-title":"Molecular mechanisms regulating protein turnover in muscle","volume":"37","author":"Price","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0170","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/j.biocel.2005.04.009","article-title":"Altered responses in skeletal muscle protein turnover during aging in anabolic and catabolic periods","volume":"37","author":"Attaix","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0175","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/SPC.0b013e3283196ac2","article-title":"Role of the ubiquitin-proteasome pathway in muscle atrophy in cachexia","volume":"2","author":"Attaix","year":"2008","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"10.1016\/j.semcancer.2016.01.002_bib0180","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1126\/science.1065874","article-title":"Identification of ubiquitin ligases required for skeletal muscle atrophy","volume":"294","author":"Bodine","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2016.01.002_bib0185","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.cardiores.2006.10.026","article-title":"Myocardial expression of Murf-1 and MAFbx after induction of chronic heart failure: effect on myocardial contractility","volume":"73","author":"Adams","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0190","doi-asserted-by":"crossref","first-page":"R971","DOI":"10.1152\/ajpregu.00617.2006","article-title":"Atrophy-related ubiquitin ligases atrogin-1 and MuRF-1 are associated with uterine smooth muscle involution in the postpartum period","volume":"292","author":"Bdolah","year":"2007","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0195","first-page":"699","article-title":"Response markers and the molecular mechanisms of action of Gleevec in gastrointestinal stromal tumors","volume":"2","author":"Frolov","year":"2003","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0200","doi-asserted-by":"crossref","first-page":"14440","DOI":"10.1073\/pnas.251541198","article-title":"Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy","volume":"98","author":"Gomes","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0205","first-page":"340","article-title":"Molecular pathways leading to cancer cachexia","volume":"20","author":"Tisdale","year":"2005","journal-title":"Physiology (Bethesda)"},{"key":"10.1016\/j.semcancer.2016.01.002_bib0210","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1128\/MCB.00666-09","article-title":"Regulation of the intracellular localization of Foxo3a by stress-activated protein kinase signaling pathways in skeletal muscle cells","volume":"30","author":"Clavel","year":"2010","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0215","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0304-3835(98)00137-2","article-title":"Protein turnover in skeletal muscle of tumour-bearing transgenic mice overexpressing the soluble TNF receptor-1","volume":"130","author":"Llovera","year":"1998","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0220","first-page":"1355","article-title":"Serum levels of tumor necrosis factor-alpha and nutritional status in pancreatic cancer patients","volume":"21","author":"Karayiannakis","year":"2001","journal-title":"Anticancer Res."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0225","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1158\/1055-9965.EPI-05-0797","article-title":"Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma","volume":"15","author":"Duell","year":"2006","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0230","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1155\/S0962935193000602","article-title":"Chronic cigarette smoking enhances spontaneous release of tumour necrosis factor-alpha from alveolar macrophages of rats","volume":"2","author":"Pessina","year":"1993","journal-title":"Mediators Inflammation"},{"key":"10.1016\/j.semcancer.2016.01.002_bib0235","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/sj.cdd.4402127","article-title":"Tumour necrosis factor-alpha inhibits adipogenesis via a beta-catenin\/TCF4(TCF7L2)-dependent pathway","volume":"14","author":"Cawthorn","year":"2007","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0240","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1006\/bbrc.1996.5827","article-title":"TNF can directly induce the expression of ubiquitin-dependent proteolytic system in rat soleus muscles","volume":"230","author":"Llovera","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0245","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1126\/science.289.5488.2363","article-title":"NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia","volume":"289","author":"Guttridge","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2016.01.002_bib0250","doi-asserted-by":"crossref","first-page":"e69356","DOI":"10.1371\/journal.pone.0069356","article-title":"TNF stimulates nuclear export and secretion of IL-15 by acting on CRM1 and ARF6","volume":"8","author":"Ouyang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2016.01.002_bib0255","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3892\/or.2012.1928","article-title":"Serum interleukin-15 levels in cancer patients with cachexia","volume":"28","author":"Martinez-Hernandez","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0260","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1006\/jmbi.2001.4448","article-title":"Identification of muscle specific ring finger proteins as potential regulators of the titin kinase domain","volume":"306","author":"Centner","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0265","doi-asserted-by":"crossref","first-page":"E469","DOI":"10.1152\/ajpendo.00204.2014","article-title":"Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx\/atrogin-1","volume":"307","author":"Bodine","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0270","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1083\/jcb.200108089","article-title":"Muscle-specific RING finger-1 interacts with titin to regulate sarcomeric M-line and thick filament structure and may have nuclear functions via its interaction with glucocorticoid modulatory element binding protein-1","volume":"157","author":"McElhinny","year":"2002","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0275","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1242\/jcs.01158","article-title":"Muscle-specific RING finger-2 (MURF-2) is important for microtubule, intermediate filament and sarcomeric M-line maintenance in striated muscle development","volume":"117","author":"McElhinny","year":"2004","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0280","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/leu.2012.361","article-title":"FBXW7 regulates glucocorticoid response in T-cell acute lymphoblastic leukaemia by targeting the glucocorticoid receptor for degradation","volume":"27","author":"Malyukova","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2016.01.002_bib0285","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.3390\/ijms16022294","article-title":"FBXW7 acts as an independent prognostic marker and inhibits tumor growth in human osteosarcoma","volume":"16","author":"Li","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0290","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-4939-2895-8_7","article-title":"Glucocorticoids and skeletal muscle","volume":"872","author":"Bodine","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0295","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0092-8674(04)00400-3","article-title":"Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy","volume":"117","author":"Sandri","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2016.01.002_bib0300","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1074\/jbc.M407517200","article-title":"Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase\/Akt\/mammalian target of rapamycin (PI3K\/Akt\/mTOR) pathway","volume":"280","author":"Latres","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0305","doi-asserted-by":"crossref","first-page":"16260","DOI":"10.1073\/pnas.0607795103","article-title":"PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription","volume":"103","author":"Sandri","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0310","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.4161\/cc.22777","article-title":"Mitochondria fuel breast cancer metabolism: fifteen markers of mitochondrial biogenesis label epithelial cancer cells, but are excluded from adjacent stromal cells","volume":"11","author":"Sotgia","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.semcancer.2016.01.002_bib0315","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1002\/pmic.201400378","article-title":"Proteomic signatures associated with p53 mutational status in lung adenocarcinoma","volume":"14","author":"Taguchi","year":"2014","journal-title":"Proteomics"},{"key":"10.1016\/j.semcancer.2016.01.002_bib0320","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1113\/jphysiol.2014.275545","article-title":"PGC1-alpha over-expression prevents metabolic alterations and soleus muscle atrophy in hindlimb unloaded mice","volume":"592","author":"Cannavino","year":"2014","journal-title":"J. Physiol."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0325","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/jcp.21955","article-title":"TNF-alpha-mediated reduction in PGC-1alpha may impair skeletal muscle function after cigarette smoke exposure","volume":"222","author":"Tang","year":"2010","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0330","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1074\/jbc.M407517200","article-title":"Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase\/Akt\/mammalian target of rapamycin (PI3K\/Akt\/mTOR) pathway","volume":"280","author":"Latres","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0335","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.cell.2012.10.050","article-title":"A PGC-1alpha isoform induced by resistance training regulates skeletal muscle hypertrophy","volume":"151","author":"Ruas","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2016.01.002_bib0340","doi-asserted-by":"crossref","first-page":"10636","DOI":"10.1128\/MCB.24.24.10636-10649.2004","article-title":"The CRM1 nuclear export receptor controls pathological cardiac gene expression","volume":"24","author":"Harrison","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0345","doi-asserted-by":"crossref","first-page":"18039","DOI":"10.1074\/jbc.M109.083121","article-title":"Regulation of NT-PGC-1alpha subcellular localization and function by protein kinase A-dependent modulation of nuclear export by CRM1","volume":"285","author":"Chang","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0350","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1042\/bj20020508","article-title":"CCAAT\/enhancer-binding proteins: structure, function and regulation","volume":"365","author":"Ramji","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0355","doi-asserted-by":"crossref","first-page":"7380","DOI":"10.1128\/MCB.24.17.7380-7391.2004","article-title":"Cell cycle-dependent phosphorylation of C\/EBPbeta mediates oncogenic cooperativity between C\/EBPbeta and H-RasV12","volume":"24","author":"Shuman","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0360","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1038\/sj.emboj.7600789","article-title":"C\/EBPbeta cooperates with RB:E2F to implement Ras(V12)-induced cellular senescence","volume":"24","author":"Sebastian","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0365","doi-asserted-by":"crossref","first-page":"953","DOI":"10.4161\/cc.5.9.2733","article-title":"Stop and go: anti-proliferative and mitogenic functions of the transcription factor C\/EBPbeta","volume":"5","author":"Sebastian","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1016\/j.semcancer.2016.01.002_bib0370","doi-asserted-by":"crossref","first-page":"R439","DOI":"10.1152\/ajpregu.00512.2001","article-title":"C\/EBP DNA-binding activity is upregulated by a glucocorticoid-dependent mechanism in septic muscle","volume":"282","author":"Penner","year":"2002","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0375","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/jcp.20278","article-title":"Expression and activity of C\/EBPbeta and delta are upregulated by dexamethasone in skeletal muscle","volume":"204","author":"Yang","year":"2005","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0380","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1002\/jcb.23093","article-title":"C\/EBPbeta regulates dexamethasone-induced muscle cell atrophy and expression of atrogin-1 and MuRF1","volume":"112","author":"Gonnella","year":"2011","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0385","first-page":"239","article-title":"Mega roles of microRNAs in regulation of skeletal muscle health and disease","volume":"5","author":"Sharma","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0390","doi-asserted-by":"crossref","first-page":"38456","DOI":"10.1074\/jbc.M111.271270","article-title":"Translational suppression of atrophic regulators by microRNA-23a integrates resistance to skeletal muscle atrophy","volume":"286","author":"Wada","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0395","doi-asserted-by":"crossref","first-page":"C551","DOI":"10.1152\/ajpcell.00266.2013","article-title":"miR-23a is decreased during muscle atrophy by a mechanism that includes calcineurin signaling and exosome-mediated export","volume":"306","author":"Hudson","year":"2014","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0400","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/ki.2012.84","article-title":"Transcription factor FoxO1, the dominant mediator of muscle wasting in chronic kidney disease, is inhibited by microRNA-486","volume":"82","author":"Xu","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0405","doi-asserted-by":"crossref","first-page":"6663","DOI":"10.1074\/jbc.M112.390369","article-title":"Muscle-specific microRNA1 (miR1) targets heat shock protein 70 (HSP70) during dexamethasone-mediated atrophy","volume":"288","author":"Kukreti","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0410","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1042\/BJ20130833","article-title":"The miR-19a\/b family positively regulates cardiomyocyte hypertrophy by targeting atrogin-1 and MuRF-1","volume":"457","author":"Song","year":"2014","journal-title":"Biochem. J."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0415","doi-asserted-by":"crossref","first-page":"22438","DOI":"10.3390\/ijms160922438","article-title":"Analysis of MicroRNA expression profiles in weaned pig skeletal muscle after lipopolysaccharide challenge","volume":"16","author":"Zhang","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0420","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1101\/gad.256495.114","article-title":"Nuclear pore proteins and the control of genome functions","volume":"29","author":"Ibarra","year":"2015","journal-title":"Genes Dev."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0425","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.bbamcr.2010.10.014","article-title":"Nuclear import by karyopherin-betas: recognition and inhibition","volume":"1813","author":"Chook","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.semcancer.2016.01.002_bib0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2014.04.011","article-title":"The evolving role of nuclear transporters in cancer","volume":"27","author":"Azmi","year":"2014","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0435","doi-asserted-by":"crossref","first-page":"6712","DOI":"10.1093\/emboj\/20.23.6712","article-title":"Nuclear export of phosphorylated C\/EBPbeta mediates the inhibition of albumin expression by TNF-alpha","volume":"20","author":"Buck","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0440","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1053\/j.gastro.2012.10.036","article-title":"Selective inhibitors of nuclear export block pancreatic cancer cell proliferation and reduce tumor growth in mice","volume":"144","author":"Azmi","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semcancer.2016.01.002_bib0445","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.18632\/oncotarget.1813","article-title":"Nuclear retention of Fbw7 by specific inhibitors of nuclear export leads to Notch1 degradation in pancreatic cancer","volume":"5","author":"Gao","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2016.01.002_bib0450","doi-asserted-by":"crossref","first-page":"16077","DOI":"10.1038\/srep16077","article-title":"Targeting the nuclear export protein XPO1\/CRM1 reverses epithelial to mesenchymal transition","volume":"5","author":"Azmi","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0455","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/nar\/gkt935","article-title":"Nuclear ubiquitination by FBXL5 modulates Snail1 DNA binding and stability","volume":"42","author":"Vinas-Castells","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0460","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1074\/jbc.M109.065995","article-title":"The hypoxia-controlled FBXL14 ubiquitin ligase targets SNAIL1 for proteasome degradation","volume":"285","author":"Vinas-Castells","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0465","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1158\/1538-7445.AM2015-1756","article-title":"Abstract 1756: preclinical activity in non-Hodgkin\u2019s lymphoma of Selinexor, a selective inhibitor of nuclear export (SINE), is enhanced through combination with standard-of-care therapies","volume":"75","author":"Azmi Asfar","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0470","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1172\/JCI119513","article-title":"Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles","volume":"100","author":"Tawa","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0475","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1006\/bbrc.2000.2398","article-title":"Sepsis-induced muscle proteolysis is prevented by a proteasome inhibitor in vivo","volume":"270","author":"Fischer","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0480","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1023\/A:1006955832323","article-title":"Manipulation of the ubiquitin-proteasome pathway in cachexia: pentoxifylline suppresses the activation of 20S and 26S proteasomes in muscles from tumor-bearing rats","volume":"26","author":"Combaret","year":"1999","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0485","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ghir.2008.12.003","article-title":"Pharmacodynamic hormonal effects of anamorelin, a novel oral ghrelin mimetic and growth hormone secretagogue in healthy volunteers","volume":"19","author":"Garcia","year":"2009","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0490","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1743-7075-2-20","article-title":"Effects of dietary curcumin or N-acetylcysteine on NF-kappaB activity and contractile performance in ambulatory and unloaded murine soleus","volume":"2","author":"Farid","year":"2005","journal-title":"Nutr. Metab. (Lond.)"},{"key":"10.1016\/j.semcancer.2016.01.002_bib0495","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/jcb.21060","article-title":"Curcumin prevents lipopolysaccharide-induced atrogin-1\/MAFbx upregulation and muscle mass loss","volume":"100","author":"Jin","year":"2007","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0500","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1017\/S0007114509345250","article-title":"Attenuation of proteolysis and muscle wasting by curcumin c3 complex in MAC16 colon tumour-bearing mice","volume":"102","author":"Siddiqui","year":"2009","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0505","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.bbrc.2010.06.126","article-title":"Curcumin decreases toll-like receptor-2 gene expression and function in human monocytes and neutrophils","volume":"398","author":"Shuto","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0510","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/tra.12090","article-title":"CRM1 is a cellular target of curcumin: new insights for the myriad of biological effects of an ancient spice","volume":"14","author":"Niu","year":"2013","journal-title":"Traffic"},{"key":"10.1016\/j.semcancer.2016.01.002_bib0515","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/01635581.2011.563032","article-title":"Oral resveratrol therapy inhibits cancer-induced skeletal muscle and cardiac atrophy in vivo","volume":"63","author":"Shadfar","year":"2011","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.semcancer.2016.01.002_bib0520","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.vph.2011.11.002","article-title":"Resveratrol reverses monocrotaline-induced pulmonary vascular and cardiac dysfunction: a potential role for atrogin-1 in smooth muscle","volume":"56","author":"Paffett","year":"2012","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0525","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.metabol.2013.05.018","article-title":"Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes","volume":"62","author":"Castillero","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.semcancer.2016.01.002_bib0530","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.intimp.2014.02.002","article-title":"Resveratrol prevents TNF-alpha-induced muscle atrophy via regulation of Akt\/mTOR\/FoxO1 signaling in C2C12 myotubes","volume":"19","author":"Wang","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0535","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.bbrc.2013.10.146","article-title":"SIRT1 suppresses cellular accumulation of beta-TrCP E3 ligase via protein degradation","volume":"441","author":"Woo","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0540","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005004.pub2","article-title":"Green tea (Camellia sinensis) for the prevention of cancer","author":"Boehm","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0545","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1756-5391.2010.01063.x","article-title":"Green tea for the prevention of cancer","volume":"3","author":"Boehm","year":"2010","journal-title":"J. Evid. Based Med."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0550","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s10787-008-8017-8","article-title":"Green tea polyphenols as a natural tumour cell proteasome inhibitor","volume":"16","author":"Dou","year":"2008","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.semcancer.2016.01.002_bib0555","doi-asserted-by":"crossref","first-page":"891","DOI":"10.2174\/187152012802649978","article-title":"Targeting tumor ubiquitin-proteasome pathway with polyphenols for chemosensitization","volume":"12","author":"Shen","year":"2012","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0560","doi-asserted-by":"crossref","first-page":"5972","DOI":"10.1210\/en.2008-0408","article-title":"EGCG stabilizes p27kip1 in E2-stimulated MCF-7 cells through down-regulation of the Skp2 protein","volume":"149","author":"Huang","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.semcancer.2016.01.002_bib0565","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.canlet.2011.02.023","article-title":"Epigallocatechin-3-gallate effectively attenuates skeletal muscle atrophy caused by cancer cachexia","volume":"305","author":"Wang","year":"2011","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcancer.2016.01.002_bib0570","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2152\/jmi.56.26","article-title":"Polyphenols prevent clinorotation-induced expression of atrogenes in mouse C2C12 skeletal myotubes","volume":"56","author":"Hemdan","year":"2009","journal-title":"J. Med. Invest."}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X16300025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X16300025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T06:25:39Z","timestamp":1589610339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X16300025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":114,"alternative-id":["S1044579X16300025"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2016.01.002","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"F-BOX proteins in cancer cachexia and muscle wasting: Emerging regulators and therapeutic opportunities","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2016.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}